GlaxoSmithKline PLC GSK-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 1:32 PM BST
1,337.40quote price arrow down-10.40 (-0.77%)
52 week range
1,190.80 - 1,748.55

...

Loading . . .
  • Open1,336.00
  • Day High1,344.40
  • Day Low1,330.80
  • Prev Close1,347.80
  • 52 Week High1,748.55
  • 52 Week High Date05/13/20
  • 52 Week Low1,190.80
  • 52 Week Low Date02/26/21

Key Stats

  • Market Cap96,308.6M
  • Shares Out5,029.98M
  • 10 Day Average Volume7.07M
  • Dividend80.00
  • Dividend Yield5.98%
  • Beta0.58
  • YTD % Change-0.42

KEY STATS

  • Open1,336.00
  • Day High1,344.40
  • Day Low1,330.80
  • Prev Close1,347.80
  • 52 Week High1,748.55
  • 52 Week High Date05/13/20
  • 52 Week Low1,190.80
  • 52 Week Low Date02/26/21
  • Market Cap96,308.6M
  • Shares Out5,029.98M
  • 10 Day Average Volume7.07M
  • Dividend80.00
  • Dividend Yield5.98%
  • Beta0.58
  • YTD % Change-0.42

RATIOS/PROFITABILITY

  • EPS (TTM)105.59
  • P/E (TTM)12.67
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/20/2021
  • Div Amount19.00
  • Split Date-
  • Split Factor-

Profile

MORE
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a...
Jonathan Symonds CBE
Non-Executive Chairman
Emma Walmsley
Chief Executive Officer
Iain Mackay
Chief Financial Officer
Address
G S K House, 980 Great West Road
Brentford
TW8 9GS
United Kingdom